BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17685214)

  • 1. Management of transitional cell carcinoma of the urinary bladder at Kenyatta National Hospital, Nairobi.
    Waihenya CG; Mungai PN
    East Afr Med J; 2006 Dec; 83(12):679-83. PubMed ID: 17685214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of transitional cell carcinoma of the urinary bladder as seen at Kenyatta National Hospital, Nairobi.
    Waihenya CG; Mungai PN
    East Afr Med J; 2004 Mar; 81(3):114-9. PubMed ID: 15293967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical radiotherapy and salvage cystectomy as the primary management of transitional cell carcinoma of the bladder. Results following the introduction of a CT planning technique.
    Borgaonkar S; Jain A; Bollina P; McLaren DB; Tulloch D; Kerr GR; Howard GC
    Clin Oncol (R Coll Radiol); 2002 Apr; 14(2):141-7. PubMed ID: 12069124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.
    Zietman AL; Grocela J; Zehr E; Kaufman DS; Young RH; Althausen AF; Heney NM; Shipley WU
    Urology; 2001 Sep; 58(3):380-5. PubMed ID: 11549485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of surveillance in the treatment of patients with muscle-invasive bladder cancer after chemotherapy.
    Hellenthal NJ; Ramirez ML; Evans CP; Devere White RW
    BJU Int; 2010 Feb; 105(4):485-8. PubMed ID: 19849694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radical cystectomy in the treatment of bladder cancer always in due time?].
    May M; Braun KP; Richter W; Helke C; Vogler H; Hoschke B; Siegsmund M
    Urologe A; 2007 Aug; 46(8):913-9. PubMed ID: 17676301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of patients with transitional cell carcinoma of the urinary bladder in indonesia: a single institution review.
    Supit W; Mochtar CA; Sugiono M; Umbas R
    Asian Pac J Cancer Prev; 2011; 12(2):549-53. PubMed ID: 21545228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
    David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of tumour grade in predicting disease progression in stage Ta transitional cell carcinoma of the urinary bladder.
    Chen SS; Chen KK; Lin AT; Chang YH; Wu HH; Hsu TH; Chang LS
    Br J Urol; 1996 Aug; 78(2):209-12. PubMed ID: 8813915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
    Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
    BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of radical cystectomy and bladder preservation treatment for muscle-invasive urothelial carcinoma of the bladder.
    Supit W; Mochtar CA; Santoso RB; Umbas R
    Asian J Surg; 2014 Oct; 37(4):184-9. PubMed ID: 24637186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of high-risk non-muscle invasive bladder cancer.
    Brausi M; Olaru V
    Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant therapy in different risk-groups of patients with superficial bladder cancer.
    Startsev V; Pouline I
    Arch Ital Urol Androl; 2005 Jun; 77(2):93-8. PubMed ID: 16146269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcomatoid urothelial carcinoma of the bladder with osseous metaplasia: bone in urinary bladder.
    Varshney B; Choudhary GR; Yadav T; Nalwa A
    BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33906873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for positive findings in patients with high-grade T1 bladder cancer treated with transurethral resection of bladder tumour (TUR) and bacille Calmette-Guérin therapy and the decision for a repeat TUR.
    Orsola A; Cecchini L; Raventós CX; Trilla E; Planas J; Landolfi S; de Torres I; Morote J
    BJU Int; 2010 Jan; 105(2):202-7. PubMed ID: 19558557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superficial bladder tumours: recurrence and progression.
    Mansoor M; Ali S; Fasihuddin Q; Baloch MU
    J Coll Physicians Surg Pak; 2011 Mar; 21(3):157-60. PubMed ID: 21419022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoma in a bladder diverticulum: presentation and treatment outcome.
    Golijanin D; Yossepowitch O; Beck SD; Sogani P; Dalbagni G
    J Urol; 2003 Nov; 170(5):1761-4. PubMed ID: 14532771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.